J Korean Soc Laryngol Phoniatr Logoped.
2020 Jun;31(1):7-12. 10.22469/jkslp.2020.31.1.7.
Prevention and Adjuvant Therapy of Recurrent Respiratory Papillomatosis
- Affiliations
-
- 1Department of Otolaryngology-Head and Neck Surgery, Dong-A University College of Medicine, Busan, Korea
- KMID: 2505860
- DOI: http://doi.org/10.22469/jkslp.2020.31.1.7
Abstract
- Recurrent respiratory papillomatosis (RRP) is characterized by repeated recurrence in the respiratory system, such as the pharynx, larynx, and trachea, caused by the human papilloma virus. The main treatment is surgical removal of the papilloma. However repeated recurrence of RRP in multiple areas is burdened for the surgeon. In addition to the surgery, various adjuvant therapies have been studied to reduce the recurrence. Literature review was conducted with a focus on the adjuvant treatments for RRP.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Recurrent Respiratory Papillomatosis
- Treatment of Recurrent Respiratory Papillomatosis Using Laser and Available Adjuvant Therapies
- Efficacy of Long-term Interferon-alpha Therapy in Adult Patients with Recurrent Respiratory Papillomatosis
- Intravenous cidofovir as an adjuvant therapy for recurrent upper airway papillomatosis with lung involvement in a child
- Clinical Findings of Recurrent Respiratory Papillomatosis and Preliminary Results of the Adjuvant Therapy
